DURACLON Side Effects

6060058-3 | Completed Suicide
on Jan 16, 2009 Male patient from UNITED STATES , 69 years of age, was treated with Duraclon (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Duraclon dosage: Po. During the same period patient was treated with AMLODIPINE (Po) (View Amlodipine Review and Amlodipine Label ), METOPROLOL TARTRATE (Po) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), SALICYLATE (Po) (View Salicylate Review and Salicylate Label ), ALBUTEROL (Po) (View Albuterol Review and Albuterol Label ), RANITIDINE (Po) (View Ranitidine Review and Ranitidine Label ), TIAGABINE HCL (Po) (View Tiagabine Hcl Review and Tiagabine Hcl Label ), DIURETIC (Po) (View Diuretic Review and Diuretic Label ), CLOPIDOGREL (Po) (View Clopidogrel Review and Clopidogrel Label ).

6060057-1 | Cardiac Arrest, Completed Suicide, Respiratory Arrest
Patient was taking Duraclon (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), completed suicide, respiratory arrest on Jan 16, 2009 from UNITED STATES Additional patient health information: Female patient , 60 years of age, . Duraclon dosage: Po. During the same period patient was treated with CLONAZEPAM (Po) (View Clonazepam Review and Clonazepam Label ), DILTIAZEM (Po) (View Diltiazem Review and Diltiazem Label ).

6060056-X | Completed Suicide
Adverse event was reported on Jan 16, 2009 by a Male patient taking Duraclon (View Usage) (Dosage: Po) . Location: UNITED STATES , 56 years of age, After Duraclon was administered, patient had the following side effects: completed suicide.

6060055-8 | Completed Suicide
on Jan 16, 2009 Male patient from UNITED STATES , 47 years of age, was treated with Duraclon (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Duraclon dosage: Po. During the same period patient was treated with VERAPAMIL (Po) (View Verapamil Review and Verapamil Label ), LABETALOL HCL (Po) (View Labetalol Hcl Review and Labetalol Hcl Label ), PROPRANOLOL (Po) (View Propranolol Review and Propranolol Label ).


6060054-6 | Completed Suicide
on Jan 16, 2009 Male patient from UNITED STATES , 51 years of age, was treated with Duraclon (View Usage). Patient had the following side effects: completed suicide. Duraclon dosage: Po. During the same period patient was treated with ASPIRIN (Po) (View Aspirin Review and Aspirin Label ), LISINOPRIL (Po) (View Lisinopril Review and Lisinopril Label ), MONTELUKAST SODIUM (Po) (View Montelukast Sodium Review and Montelukast Sodium Label ), FLUOXETINE HCL (Po) (View Fluoxetine Hcl Review and Fluoxetine Hcl Label ), LAMOTRIGINE (Po) (View Lamotrigine Review and Lamotrigine Label ), POTASSIUM CHLORIDE (Po) (View Potassium Chloride Review and Potassium Chloride Label ), TRAMADOL HCL (Po) (View Tramadol Hcl Review and Tramadol Hcl Label ), HYDROCHLOROTHIAZIDE (Po) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6060053-4 | Cardiac Arrest, Respiratory Arrest
Patient was taking Duraclon (View Usage). After Duraclon was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), respiratory arrest on Jan 16, 2009 from UNITED STATES Additional patient health information: Male patient , child 6 years of age, . Duraclon dosage: Po.

6060052-2 | Completed Suicide
Adverse event was reported on Jan 16, 2009 by a Male patient taking Duraclon (View Usage) (Dosage: Po) . Location: UNITED STATES , 45 years of age, Patient experienced the following unwanted or unexpected effects: completed suicide. During the same period patient was treated with AMLODIPINE (Po) (View Amlodipine Review and Amlodipine Label ), METOPROLOL TARTRATE (Po) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), METFORMIN HCL (Po) (View Metformin Hcl Review and Metformin Hcl Label ), ROSIGLITAZONE (Po) (View Rosiglitazone Review and Rosiglitazone Label ), SIMVASTATIN (Po) (View Simvastatin Review and Simvastatin Label ).

6060051-0 | Cardiac Arrest, Respiratory Arrest
on Jan 16, 2009 Female patient from UNITED STATES , 52 years of age, was treated with Duraclon (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), respiratory arrest. Duraclon dosage: Po. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM (View Fentanyl Transdermal System Review and Fentanyl Transdermal System Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ).

5613098-X |
on Jan 14, 2008 Male patient from UNITED STATES , 51 years of age, was treated with Duraclon (View Usage). . Duraclon dosage: Po. During the same period patient was treated with AMITRIPTYLINE HCL (Po) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), METOPROLOL TARTRATE (Po) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), MINOXIDIL (Po) (View Minoxidil Review and Minoxidil Label ).

5613097-8 | Cardiac Arrest, Completed Suicide, Respiratory Arrest
Patient was taking Duraclon (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), completed suicide, respiratory arrest on Jan 14, 2008 from UNITED STATES Additional patient health information: Male patient , 41 years of age, . Duraclon dosage: Po. During the same period patient was treated with CYCLOBENZAPRINE HCL (Po) (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), ENALAPRIL MALEATE (Po) (View Enalapril Maleate Review and Enalapril Maleate Label ), HYDROCODONE/ACETAMOPHEN (Po) (View Hydrocodone/acetamophen Review and Hydrocodone/acetamophen Label ).

5613096-6 | Cardiac Arrest, Completed Suicide, Respiratory Arrest
Adverse event was reported on Jan 14, 2008 by a Male patient taking Duraclon (View Usage) (Dosage: Po) . Location: UNITED STATES , 41 years of age, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), completed suicide, respiratory arrest. During the same period patient was treated with CARISOPRODOL (Po) (View Carisoprodol Review and Carisoprodol Label ).

5613095-4 | Completed Suicide
on Jan 14, 2008 Female patient from UNITED STATES , 15 years of age, was treated with Duraclon (View Usage). After Duraclon was administered, patient had the following side effects: completed suicide. Duraclon dosage: Po. During the same period patient was treated with BUPROPION HCL (Po) (View Bupropion Hcl Review and Bupropion Hcl Label ), TOPTOPIRAMATEAMAX (Po) (View Toptopiramateamax Review and Toptopiramateamax Label ), FLUOXETINE (Po) (View Fluoxetine Review and Fluoxetine Label ), SSRI (Po) (View Ssri Review and Ssri Label ).

5613089-9 |
on Jan 14, 2008 Female patient from UNITED STATES , 71 years of age, was treated with Duraclon (View Usage). . Duraclon dosage: Po. During the same period patient was treated with CARDIAC GLYCOSIDE (Po) (View Cardiac Glycoside Review and Cardiac Glycoside Label ), CALCIUM ANTAGOINIST (Po) (View Calcium Antagoinist Review and Calcium Antagoinist Label ), LISINOPRIL (Po) (View Lisinopril Review and Lisinopril Label ), CARVEDILOL (Po) (View Carvedilol Review and Carvedilol Label ), ATORVASTATIN CALCIUM (Po) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), FAMOTIDINE (Po) (View Famotidine Review and Famotidine Label ).

5613088-7 | Cardiac Arrest, Completed Suicide, Respiratory Arrest
Patient was taking Duraclon (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), completed suicide, respiratory arrest on Jan 14, 2008 from UNITED STATES Additional patient health information: Female patient , 25 years of age, . Duraclon dosage: Po. During the same period patient was treated with OLMESARTAN MEDOXOMIL (Po) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), PREGABALIN (Po) (View Pregabalin Review and Pregabalin Label ), NITROGLYCERIN (Po) (View Nitroglycerin Review and Nitroglycerin Label ), EXETIMIBE (Po) (View Exetimibe Review and Exetimibe Label ).

5613079-6 | Completed Suicide
Adverse event was reported on Jan 14, 2008 by a Female patient taking Duraclon (View Usage) (Dosage: Po) . Location: UNITED STATES , 28 years of age, After Duraclon was administered, patient had the following side effects: completed suicide. During the same period patient was treated with DILTIAZEM (Po) (View Diltiazem Review and Diltiazem Label ), BUPROPION HCL (Po) (View Bupropion Hcl Review and Bupropion Hcl Label ), QUETIAPINE FUMARATE (Po) (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), ZIPRASIDONE HCL (Po) (View Ziprasidone Hcl Review and Ziprasidone Hcl Label ), GABAPENTIN (Po) (View Gabapentin Review and Gabapentin Label ), TIZANIDINE HCL (Po) (View Tizanidine Hcl Review and Tizanidine Hcl Label ), DULOXETINE (Po) (View Duloxetine Review and Duloxetine Label ).

5613078-4 | Cardiac Arrest, Completed Suicide, Respiratory Arrest
on Jan 14, 2008 Male patient from UNITED STATES , 39 years of age, was treated with Duraclon (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), completed suicide, respiratory arrest. Duraclon dosage: Po. During the same period patient was treated with ETHANOL (Po) (View Ethanol Review and Ethanol Label ).

5264404-X | Blood Pressure Decreased, Cardiac Arrest, Diastolic Dysfunction, Overdose, Pulse Absent, Sinus Bradycardia
on Feb 26, 2007 Female patient from UNITED STATES , child 5 years of age, weighting 37.04 lb, was diagnosed with restlessness and was treated with Duraclon (View Usage). Patient had the following side effects: blood pressure decreased, cardiac arrest (What is cardiac arrest?), diastolic dysfunction, overdose, pulse absent, sinus bradycardia. Duraclon dosage: 0.1 Mg; Prn; Gt. During the same period patient was treated with SEVOFLURANE (8 Pct; 1x; Inh) (View Sevoflurane Review and Sevoflurane Label ), NITROUS OXIDE W/ OXYGEN (1x; Inh) (View Nitrous Oxide W/ Oxygen Review and Nitrous Oxide W/ Oxygen Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), BACLOFEN (View Baclofen Review and Baclofen Label ). Patient was hospitalized.

5129617-6 | Completed Suicide, Incorrect Dose Administered
Patient was taking Duraclon (View Usage). After Duraclon was administered, patient had the following side effects: completed suicide, incorrect dose administered on Oct 02, 2006 from UNITED STATES Additional patient health information: Female patient , 44 years of age, . Duraclon dosage: Oral. During the same period patient was treated with CLONAZEPAM (Oral) (View Clonazepam Review and Clonazepam Label ), ATENOLOL (Oral) (View Atenolol Review and Atenolol Label ).

5129610-3 | Cardiac Arrest, Respiratory Arrest
Adverse event was reported on Oct 02, 2006 by a Female patient taking Duraclon (View Usage) (Dosage: ) . Location: UNITED STATES , 25 years of age, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), respiratory arrest. During the same period patient was treated with AMITRIPTYLINE HCL (Oral) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ).

5129252-X | Cardiac Arrest, Completed Suicide, Respiratory Arrest
on Oct 02, 2006 Female patient from UNITED STATES , 19 years of age, was treated with Duraclon (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), completed suicide, respiratory arrest. Duraclon dosage: .

5129247-6 | Cardiac Arrest, Completed Suicide, Respiratory Arrest
on Oct 02, 2006 Female patient from UNITED STATES , 67 years of age, was treated with Duraclon (View Usage). After Duraclon was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), completed suicide, respiratory arrest. Duraclon dosage: Oral. During the same period patient was treated with DIAZEPAM (Oral) (View Diazepam Review and Diazepam Label ).

5129245-2 | Completed Suicide
Patient was taking Duraclon (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide on Oct 02, 2006 from UNITED STATES Additional patient health information: Female patient , 35 years of age, . Duraclon dosage: Oral. During the same period patient was treated with VERAPAMIL (Oral) (View Verapamil Review and Verapamil Label ), METOPROLOL (Oral) (View Metoprolol Review and Metoprolol Label ).

5037127-X | Bradycardia, Dizziness Postural, Hypotension, Overdose
Adverse event was reported on Jun 05, 2006 by a Female patient taking Duraclon (View Usage) (Dosage: 1 Mg Once Ep) was diagnosed with anaesthesia and. Location: UNITED STATES , 53 years of age, weighting 154.3 lb, Patient had the following side effects: bradycardia, dizziness postural, hypotension, overdose. During the same period patient was treated with LIDOCAINE (75 Mg Once Ep) (View Lidocaine Review and Lidocaine Label ). Patient was hospitalized.

4964150-3 | Bradycardia, Dizziness, Hypotension, Overdose
on Mar 15, 2006 Female patient from UNITED STATES , 53 years of age, was diagnosed with anaesthesia and was treated with Duraclon (View Usage). After Duraclon was administered, patient had the following side effects: bradycardia, dizziness (What is dizziness?), hypotension, overdose. Duraclon dosage: 1 Mg Once Ep. During the same period patient was treated with LIDOCAINE (75 Mg Once Ep) (View Lidocaine Review and Lidocaine Label ). Patient was hospitalized.

4849759-X | Hypotension
on Oct 15, 2004 Male patient from UNITED STATES , 69 years of age, was diagnosed with pain (What is pain?) and was treated with Duraclon (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension. Duraclon dosage: Df. During the same period patient was treated with BACLOFEN (Df) (View Baclofen Review and Baclofen Label ), ZICONOTIDE (Df Once It) (View Ziconotide Review and Ziconotide Label ). Patient was hospitalized.